PFE vs TTD: Which Is the Better Buy?

Side-by-side comparison of Pfizer Inc. and The Trade Desk, Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-18.
Pfizer Inc. Β· Healthcare
$27.64
+12.0% upside to fair value
Med Conviction Grade B
VS
The Trade Desk, Inc. Β· Communication Services
$14.26
-1.8% upside to fair value
Med Conviction Grade C High Quality
QuantHub Verdict
PFE has more upside to fair value (+12.0%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric PFE TTD
Current Price $27.64 $14.26
Fair Value Estimate $30.94 $14.00
Upside to Fair Value +12.0% -1.8%
Market Cap $157.5B $6.7B
Forward P/E β€” β€”
EV / EBITDA 17.4x 7.5x
Price / Sales 2.5x 2.2x
Price / FCF 14.3x 7.8x
Revenue Growth YoY +2.6% +3.0%
Gross Margin 71.3% 83.0%
Operating Margin 25.1% 19.6%
Return on Equity 4.9% 16.1%
Dividend Yield 6.22% 0%
FCF Yield 6.97% 12.89%
Analyst Consensus Hold Hold
Investment Thesis
PFE β€” Pfizer Inc.
Pfizer is a global biopharmaceutical leader with a portfolio spanning cardiovascular, oncology, vaccines, immunology, and rare disease, anchored by Eliquis, the Prevnar family, Vyndaqel, Ibrance, Xtandi, Comirnaty, and Paxlovid, and supported by roughly 75,000 employees and a contract manufacturing division. Business quality is medium rather than high: TTM gross margin of 71.3% and TTM operating …
TTD β€” The Trade Desk, Inc.
The Trade Desk operates a self-service, cloud-based demand-side platform that lets advertising agencies and their advertiser clients plan, buy and optimize data-driven digital campaigns across display, video, audio, native, social and connected TV, with 3,843 employees and a founder-led management team. Business quality is genuinely high on the unit economics: TTM gross margin of 83.0%, TTM opera…
Accumulation Zones
Metric PFE TTD
Zone Low $23.21 $10.50
Zone High $26.30 $11.90
In Buy Zone? No No
← PFE Research    TTD Research β†’    All Research